Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LIALDA safely and effectively. See full prescribing information for LIALDA. LIALDA® (mesalamine) delayed-release tablets, for oral use Initial U.S. Approval: 1987
Medication labelWhy this: Advisory · dailymed-prescription
LIALDA® is indicated for the: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.
- generic_name
- mesalamine
- product_names
- mesalamine
- ndc
- 54092-476, 54092-476-08, 54092-476-01, 54092-476-12, 54092-476-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en